Evidence in Medical Technology

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

SCOTTSDALE, Ariz., July 15 /PRNewswire-USNewswire/ -- Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease . Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the c...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

ROCKVILLE, Md., July 6 /PRNewswire-USNewswire/ -- A procedure that sends targeted energy into the heart through a catheter can be used to treat a common type of irregular heartbeat, but little is known about the treatment's long-term benefits and the best methods and circumstances for applying it,...

ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009

ADDISON, Texas, March 18 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of diabetic foot ulcers, and data on the use of its patented Nanoflex(TM) Technology for Therapeutic Delivery will be presented at the annual DFCon Global Meeting...

New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults

SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Posit Science Corporation researcher, Dan Tinker, presented evidence at the Society for Neuroscience Annual Conference in Washington, DC this week indicating that cognitive training may benefit Baby Boomers. The computerized brain plasticity-based Brain Fitn...

Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported a data analysis showing that vicriviroc, its investigational CCR5 receptor antagonist, demonstrate...

The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC

Summary: Protein Tomography(TM) has yet Again Provided Structural Proof of a Drug Target Function. A Study Performed by Sidec and UCB, Characterizes the Target of Anti-Epileptic Drug in Situ Where Two Major Conformations Have Been Identified STOCKHOLM, September 9 /P...

New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence

Results add to body of clinical evidence demonstrating the efficacy and safety of synthetic mesh slings for treatment of stress urinary incontinence in women. SOMERVILLE, N.J., Sept. 8 /PRNewswire/ -- A new study published in the August issue of International Urogyne...

American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast

WASHINGTON, Sept. 1 /PRNewswire-USNewswire/ -- There has been recent concern that suicide may be a complication of montelukast (Singulair) therapy. Montelukast is a Food and Drug Administration (FDA) approved oral drug that has been prescribed for more than a decade for the treatment of asthma...

Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers

FORT WORTH, Texas, July 30 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today an evidence based study with a NE podiatric clinic evaluating the clinical performance of their advanced wound care collagen ...

Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation

Eligen(R) B12 oral formulation demonstrates 240% improvement in bioavailability versus standard oral Vitamin B12 tablet and different absorption characteristics Eligen(R) B12 absorption time was 30 minutes - Public Conference Call to discuss results and future direction set for July 29 - ...

New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer

Findings Published in August Issue of Journal of Nutrition NEW YORK, July 18 /PRNewswire/ -- Drinking four to five cups of tea a day may help maintain a healthy mind and body, according to new research published in a supplement to the August issue of the Journal of Nutrition. One study'...

BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial

- Second instance where survival increase is observed in advanced non-small cell lung cancer patients receiving Tavocept in conjunction with standard chemotherapy - Median survival increase of 6.5 months seen for patients with adenocarcinoma, the most comm...

Wound Management Technologies, Inc. Announces Evidence Based Study

FORT WORTH, Texas, June 3 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc. (formerly MB Software Corporation (OTC Bulletin Board: MBSB)) announced today that it will begin an evidence based study evaluating the clinical performance of t...

New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain

Results presented at the 27th Annual Meeting of the American Pain Society (APS) SMYRNA, Ga., May 8 /PRNewswire/ -- Patients treated with lacosamide demonstrated sustained pain relief from diabetic neuropathic pain (DNP), compared to placebo-treated patients, acco...

Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit

WHITE PLAINS, N.Y., AUG. 2 /PRNewswire-USNewswire/ -- Two major studies published today in The New England Journal of Medicine can help doctors better identify pregnant women at risk for preterm delivery who can benefit from progesterone treatment, the March of Dimes Foundation said today. In...

British Journal of Cancer Reports Preclinical Evidence of Positive Effect of Rice Bran on Intestinal Cancer

Study Shows 51% Reduction in Intestinal Adenomas Suggesting Possible Beneficial Mediation in the Prevention of Intestinal Cancer EL DORADO HILLS, Calif., March 07, 2007 /PRNewswire/ -- NutraCea announced today the results of a study on the effect of rice bran on the number of intestinal adenomas i...

Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response

LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, discussed results from two pre-clinical studies that provide evidence for chemotherapy induced angiogenesis and rationale for combining nab-paclitaxel (ABRAXANE(R) f...

Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers

- Journal of Clinical Oncology publishes first clinical study of HGS-ETR1 - ROCKVILLE, Md., April 27, 2007 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today reported that clinical and preclinical evidence continues to emerge demonstrating that its TRAIL receptor antibodies, HGS-ETR1 (map...

Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD

SEATTLE--(BUSINESS WIRE)--May 29, 2007 - Mitopharm Corporation, Inc. (Pink Sheets:MTPM), releases the results of a research paper where Professor Dr. Robert Ko published the beneficial effects of Schisandrin B, the precursor of (-) Schisandrin B - a novel discovery by Dr. Ko - on Ischemic Heart Dis...

Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference

PARIS--(BUSINESS WIRE)--Jun 4, 2007 - Hemispherx Biopharma, Inc. (AMEX: HEB), a biopharmaceutical company engaged in the clinical development of new drug entities for the treatment of pandemic disease threats, announced today a new scientific report on the activity of its experimental therapeutic A...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... OncoGenex reported that OGX-427 was well tolerated as a monotherapy in a Phase 1 study and demonstrated declines in circulating tumor cells and evidence of reduction in tumor markers. Eli Lilly and Company recently completed its Phase 1 study of LY2181308 and presented data confirming that LY21...

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

...ones secreted by the body as we reach middle age--replacing them with artificial GH, in theory, would slow the aging process. However, there is little evidence to suggest that it is effective. Very few studies have tested the combined effects of GH and sex-steroids on glucose tolerance, elevated chol...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

...ities. A median of 4.5 cycles was delivered in each cohort. The best response was stable disease in nine patients. Two patients remain without evidence of disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months. This poster ...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

...nt than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly known as R7128). In vitro studies of PSI-7851 have not shown evidence of any mitochondrial or other cellular toxicities that may be associated with some nucleoside analogs. Like RG7128, PSI-7851 has demonstrated pan geno...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

...troke treatment. Thus, continued Nogueira, when brain imaging studies revealed that a significant number of late-presenting stroke patients showed evidence of salvageable brain tissue in the area of the stroke, it was an important avenue to pursue. This meant that endovascular therapy (performed by neuro...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...ation. "We've been aware that certain antidepressants, known as CYP2D6 inhibitor drugs, block the activation of tamoxifen chemically, but this evidence shows that these drugs are putting women in New Jersey and across the nation at a much higher risk for recurrent breast cancer," said Dr. Milayna Suba...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...oid Aneurysm Trial (ISAT) - which ultimately was halted due to overwhelming evidence that minimally invasive coiling (an endovascular therapy) was, on average, ... unethical to randomize patients to coiling versus clipping following sound evidence that demonstrates that if an aneurysm is suitable for either treatment, tha...

Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest

...Emergency Department at Providence Tarzana. The hypothermia therapy has been developed and studied in recent years and now, having reviewed the evidence and the successful implementation of the program at Providence Tarzana, Providence Health & Services is creating protocols for its two other Valle...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...er Science Park, a development that shows tangible evidence that New York is positioning itself to become a hu... Company's decision to become its anchor tenant is evidence that our work is paying off. It also serves as a ...he City can and will succeed." As further evidence of innovation, Lilly also said that it now has six...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

...nd around the body. Some people find healing touch relaxing. There's little evidence to suggest other health benefits. Qi gong: The Chinese word "qi...w the progress of age-related macular degeneration. However, there's little evidence that vitamin C prevents colds or lessens cold symptoms. Vitamin ...

CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment

...ive coverage policy for the measurement of exhaled nitric oxide (eNO). The Medical Directors of CareFirst determined that the published, peer-reviewed evidence is sufficient to support benefit coverage for the treatment of asthma. The policy, effective July 20, 2009, states the measurement of exhaled nitric o...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...s growing research field is a key to understanding how probiotic food might contribute to good health in all ages. "Each year, promising new evidence on the benefits of probiotics on human health continues to emerge," said Sven Thormahlen, Executive Vice President R&D, Danone Research. "We hope ...

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

...2 picoplatin. The trial was conducted at seven clinical sites in the United States. Results showed no clinical cardiac-related events. In addition, no evidence of a clinically relevant trend in any ECG parameter was demonstrated. "With these new picoplatin safety data, we continue to make progress to...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...t. Significant viral load reductions were observed in the three higher dose cohorts (50, 75 and 100 mg/day). Post-treatment viral load data suggest no evidence of drug accumulation. The table below summarizes mean HCV RNA reductions observed in this study per cohort: En...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... using the Vitrea(R) imaging software program by Vital Images. By using this imaging approach, Dr. Harbut was able to demonstrate that: evidence based on the CT findings, the physical examination, pulmonary function studies, epidemiology and history of the patient's intractable pleural pain...

New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD

...uestioned the efficacy of Neurofeedback and whether it can be considered an evidence Based treatment or not. In collaboration with researchers from Tubin...r ADHD, but do not automatically imply that Neurofeedback can be considered evidence based for any disorder. The efficacy of Neurofeedback has to be assessed se...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...dy (ADCS) supported by the U.S. National Institute on Aging (NIA) showed no evidence for benefit in the studied population. The results do not support the routi...hase III Alzheimer's Drug Raises Level of a Toxic Protein Recent evidence suggests that the drug Dimebon may improve cognitive function in people wit...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

...variant, this latest discovery has been replicated in numerous populations by us and others, and the connection to cardioembolic stroke is yet further evidence that we are putting our finger on an important pathway involved in AF and stroke risk. The ability to routinely test for these risk factors means that...

GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas

... working capacity at the fatigue threshold (PWC(FT)). The PWC(FT) test estimates the highest power output that can be maintained without neuromuscular evidence of fatigue. Using a cycle ergometer (stationary bicycle), all subjects performed an incremental test to exhaustion prior to supplementation and a...

Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class

... SAN DIEGO, July 13 /PRNewswire/ -- Research published in the June 26, 2009 edition of Proceedings of National Academy of Sciences provides further evidence for novel roles of tRNA synthetases in disease, validating the therapeutic potential for aTyr Pharma's new class of naturally occurring protein agents...